Pythia Labs
Pythia Labs provides software that accelerates discovery and design of biomolecules for drug development. It uses Deep Learning to model and design biological molecules as part of R&D workflows. The product is a B2B software suite for the pharmaceutical and biotech industries. Key integrations include data pipelines and computational biology tooling. The platform targets large-scale research and development needs, helping teams scale drug discovery.
Pythia Labs
Pythia Labs provides software that accelerates discovery and design of biomolecules for drug development. It uses Deep Learning to model and design biological molecules as part of R&D workflows. The product is a B2B software suite for the pharmaceutical and biotech industries. Key integrations include data pipelines and computational biology tooling. The platform targets large-scale research and development needs, helping teams scale drug discovery.
TL;DR
What they do: Deep-learning software to model and design biomolecules for drug discovery
Customers / market: Pharmaceutical and biotech R&D teams (B2B)
Headquarters: Los Angeles, California
Founded: 2017
Stage / funding: Seed (seed round reported Sep 1, 2021)
Company Overview
Problem Domain
Biomolecular discovery and design for drug development; AI/ML-driven computational biology.
Founded
2017
Industry
Biotechnology
Tech Stack
Funding Track Record
Crunchbase lists a Seed round announced Sep 1, 2021; amount and lead investor are not disclosed in provided evidence.